Jereme M. Sylvain - Sep 9, 2024 Form 4 Insider Report for DEXCOM INC (DXCM)

Role: EVP, Chief Financal Officer
Signature: /s/ Jereme M. Sylvain
Stock symbol: DXCM
Transactions as of: Sep 9, 2024
Transactions value $: -$51,586
Form type: 4
Date filed: 9/11/2024, 07:05 PM
Previous filing: Jun 11, 2024
Next filing: Nov 18, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	DXCM	Common Stock	Sale	-$51.6K	-746	-0.88%	$69.15	84.3K	Sep 9, 2024	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
F2	Included in this number are 49,085 unvested restricted stock units, 26,053 of which were granted on March 8, 2024 and shall vest through March 8, 2027, 14,512 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 7,060 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 1,460 of which were granted on December 15, 2021 and shall vest through December 15, 2024, and 72 shares acquired under the Issuer's 2015 Employee Stock Purchase Plan on August 30, 2024.

Content

Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Included in this number are 49,085 unvested restricted stock units, 26,053 of which were granted on March 8, 2024 and shall vest through March 8, 2027, 14,512 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 7,060 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 1,460 of which were granted on December 15, 2021 and shall vest through December 15, 2024, and 72 shares acquired under the Issuer's 2015 Employee Stock Purchase Plan on August 30, 2024.